Guizhou Tiandi Pharmaceutical Co., LTD., founded in August 1995, the original factory is located in No. 1 Fengyi Road, Xingyi City. In August 2017, according to the requirements of urban development planning of Xingyi City and national environmental protection requirements, Guizhou Tiandi Pharmaceutical Co., LTD relocated to other places and settled in Red Star Pharmaceutical Industrial Park, Yilong New District, Guizhou Province in November 2018. Through the relocation, guizhou pharmaceutical equipment upgrade, backward production capacity of heaven and earth to be eliminated, facilities for environmental protection, to become a green, environmental protection, high degree of automation, intelligent modern enterprises, employment of nearly 600 people, the large capacity injection production line 4 24 6 injection, small volume injection production lines 17 injection, The annual production capacity of high-volume injection is 360 million bottles, and that of small-volume injection is 1.2 billion bottles. The products are mainly sold to guizhou, Yunnan, Guangxi, Guangdong and other 18 provinces (regions), processing and export products to South America, Africa and some countries in Central Asia. Since settled in Yilong Red Star Pharmaceutical Industrial Park, Guizhou Tiandi pharmaceutical production capacity released year by year, tax increased year by year. In 2020, due to the impact of COVID-19, the annual sales revenue reached RMB 200 million.
In 2021, affected by the epidemic and other factors, the domestic sales of the pharmaceutical industry declined seriously, and Guizhou Tiandi Pharmaceutical was no exception. To actively seek development, guizhou tiandi pharmaceutical by drugs with domestic professional export trading company friendship and cooperation, in the 2020 s, on the basis of processing and exports totaled 100 million yuan, efforts to expand the trust-agent processing and export trade business model, enterprise sales soared, 1-8 month accumulative total sales income over one hundred million yuan, That's up 75% from the same period last year. At the end of 2020, the three special production lines for foreign trade products have been put into production, and the annual sales revenue is expected to exceed 250 million yuan.